CytomX Therapeutics, Inc. (CTMX)
2.34
+0.05
(+2.18%)
USD |
NASDAQ |
Oct 30, 16:00
2.37
+0.03
(+1.28%)
After-Hours: 20:00
CytomX Therapeutics Price to Book Value : 1.688 for Oct. 30, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 30, 2026 | 1.688 |
| October 29, 2026 | 1.652 |
| October 28, 2026 | 1.702 |
| October 27, 2026 | 1.666 |
| October 26, 2026 | 1.605 |
| October 23, 2026 | 1.674 |
| October 22, 2026 | 1.760 |
| October 21, 2026 | 1.731 |
| October 20, 2026 | 1.811 |
| October 19, 2026 | 1.688 |
| October 16, 2026 | 1.645 |
| October 15, 2026 | 1.738 |
| October 14, 2026 | 1.609 |
| October 13, 2026 | 1.677 |
| October 12, 2026 | 1.746 |
| October 09, 2026 | 1.854 |
| October 08, 2026 | 1.782 |
| October 07, 2026 | 1.840 |
| October 06, 2026 | 1.847 |
| October 05, 2026 | 1.861 |
| October 02, 2026 | 1.847 |
| October 01, 2026 | 1.897 |
| September 30, 2026 | 1.962 |
| September 29, 2026 | 1.984 |
| September 28, 2026 | 1.940 |
| Date | Value |
|---|---|
| September 25, 2026 | 1.948 |
| September 24, 2026 | 1.984 |
| September 23, 2026 | 2.005 |
| September 22, 2026 | 2.121 |
| September 21, 2026 | 1.991 |
| September 18, 2026 | 1.991 |
| September 17, 2026 | 2.034 |
| September 16, 2026 | 1.995 |
| September 15, 2026 | 1.940 |
| September 14, 2026 | 2.308 |
| September 11, 2026 | 2.373 |
| September 10, 2026 | 2.417 |
| September 09, 2026 | 2.554 |
| September 08, 2026 | 2.633 |
| September 04, 2026 | 2.676 |
| September 03, 2026 | 2.655 |
| September 02, 2026 | 2.684 |
| September 01, 2026 | 2.647 |
| August 31, 2026 | 2.424 |
| August 28, 2026 | 2.316 |
| August 27, 2026 | 2.467 |
| August 26, 2026 | 2.395 |
| August 25, 2026 | 2.431 |
| August 24, 2026 | 2.373 |
| August 21, 2026 | 2.366 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Regeneron Pharmaceuticals, Inc. | 3.026 |
| ACADIA Pharmaceuticals, Inc. | 2.712 |
| Alnylam Pharmaceuticals, Inc. | 6.129 |
| Anika Therapeutics, Inc. | 2.042 |
| Savara, Inc. | 6.891 |
Price to Book Value Related Metrics
| PS Ratio | 23.38 |
| Price | 2.34 |
| Earnings Yield | -19.53% |
| Market Cap | 509.88M |